Organ preservation strategies for rectal cancer treatment: tarts or trap?
Total mesorectal excision (TME) is the standard treatment for advanced mid- and low-rectal cancer. However, the associated surgical complications and subsequent impairment of organ function limit its application. In recent years, with advancements in neoadjuvant chemoradiotherapy and the implementat...
Saved in:
Main Author: | ZHOU Yihang, ZENG Ziwei, KANG Liang |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Office of Journal of Surgery Concepts & Practice
2024-09-01
|
Series: | Waike lilun yu shijian |
Subjects: | |
Online Access: | https://www.qk.sjtu.edu.cn/jscp/fileup/1007-9610/PDF/1737619500094-1066784943.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
γ/δ Cells in Fetal, Neonatal, and Adult RatLymphoid Organs
by: P. Kühnlein, et al.
Published: (1995-01-01) -
Organ Function Preservation in Locally Advanced Low Rectal Cancer Through Total Neoadjuvant Therapy: A Case Report and Literature Review
by: Liu F, et al.
Published: (2025-01-01) -
Cost-effectiveness of watchful waiting versus immediate emergency department transfer after epinephrine autoinjector use in Canada
by: Yiwei Yin, et al.
Published: (2025-01-01) -
Impact on CD4+ CD25High-CD127low regulatory T (Treg) cells of neoadjuvant therapy for rectal cancer patients
by: Liu Maoxi, et al.
Published: (2023-07-01) -
Efficacy and safety of transanal endoscopic microsurgery for early rectal cancer: a meta-analysis
by: Chunqiang Wang, et al.
Published: (2025-02-01)